The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate, or grow ...

Jennifer A. Doudna was born February 19th ... they decide to collaborate and study the function of Cas9 proteins in S. pyogenes. They suspect that the longer CRISPR-RNA is what identifies the ...

Emmanuelle Charpentier and Jennifer Doudna are the first two women to share ... During Prof Charpentier's studies of the bacterium Streptococcus pyogenes, she discovered a previously unknown ...

Last year, in a study published in the Proceedings of ... “What are the unintended consequences of genome editing?” asked Jennifer Doudna, as we spoke in her office at the University of ...

It’s been a mere 11 years since Professors Jennifer Doudna and Emmanuelle Charpentier published their ... The Nature Biotechnology paper is a proof-of-principle study exploring their capacity for in ...

A frozen “ocean world” is the likeliest place in the solar system to foster alien life. Louise Prockter and her colleagues ...

Jennifer Doudna says she is an “unlikely success ... APOE-4 gene are 12 times as likely to develop the condition, some studies suggest. “There definitely are some genetic susceptibilities ...

Jennifer Doudna, awarded the Nobel Prize for her work ... the first company to achieve in vivo gene editing in an in-human study. Back in June 2022, I posted a note to Seeking Alpha covering ...

JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on NTLA stock, giving a Buy rating on October 16. Debanjana ...

Zhu also points out that the Phase 1 study’s inclusion of a high percentage ... Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

In its early years, the technology led to the death in 1999 of a 17-year-old clinical trial participant, Jesse Gelsinger, ...